Sign Up to like & get
recommendations!
0
Published in 2025 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-025-02711-1
Abstract: Myelodysplastic syndromes (MDS) can progress to AML and often require allogeneic hematopoietic stem cell transplantation (allo-SCT). The sequential FLAMSA-FB regimen, featuring a cytoreductive FLAMSA phase followed by fludarabine-busulfan (FB) conditioning, may enhance disease control. We…
read more here.
Keywords:
patients blasts;
untreated mds;
mds patients;
conditioning ... See more keywords